Want to join the conversation?
$DRI posted improved earnings in 1Q17, helped by higher sales and operating income compared to 1Q16. Earnings from continuing operations were $111.1MM or $0.88 per diluted share compared to $81MM or $0.63 per diluted share last year. Total sales from continuing operations grew 1.6% from last year to $1.71Bil. Adjusted diluted net EPS was $0.88.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?